共 50 条
- [3] Time to blast clearance predicts outcome in patients with acute myeloid leukemia [J]. Nature Clinical Practice Oncology, 2008, 5 (6): : 300 - 300
- [5] AZACITIDINE (AZA) IMPROVES OVERALL SURVIVAL (OS) IN WHO ACUTE MYELOID LEUKEMIA (AML) IN ELDERLY PATIENTS WITH LOW BONE MARROW BLAST COUNTS [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 430 - 431